CYRX 財務： Cryoport Inc AI 分析

Q: Cryoport Inc'in temel mali tabloları nelerdir?

Son mali tabloya (Form-10K) göre, Cryoport Inc'in toplam varlıkları $703 olup, net 損失 $-122'dir.

Q: CYRX'ün temel finansal oranları nelerdir?

Cryoport Inc'in cari oranı 2.33, net kâr marjı -53.5, hisse başına satış $4.62'dir.

Q: Cryoport Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Cryoport Inc 最大收入來源為 Life Sciences Services，在最近的收益報告中收入為 156,951,000。就地區而言，Americas 是 Cryoport Inc 的主要市場，收入為 126,373,000。

Q: Cryoport Inc kârlı mı?

無, son mali tablolara göre Cryoport Inc'in net 損失 $-122'dir.

Q: Cryoport Inc'in herhangi bir yükümlülüğü var mı?

是的, Cryoport Inc'in yükümlülüğü 301'dir.

Q: Cryoport Inc'in tedavüldeki hisse sayısı kaçtır?

Cryoport Inc'in toplam tedavüldeki hisse sayısı 49.9'dir.

首頁

股票

CYRX

CYRX 財務

Cryoport Inc

$10.88

-1.35%

$-0.14

截至今日：Jan 20, 12:23:01 GMT-5

概觀預測收益股利財務狀況

關鍵數據

前收市價

$11.03

開盤價

$10.72

當日範圍

$10.72 - $10.93

52週區間

$4.58 - $11.44

交易量

157.9K

平均成交量

594.2K

每股盈餘 (TTM)

1.34

股息收益率

市值

$544.7M

什麼是 CYRX？

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 1,090 full-time employees. The company went IPO on 2015-07-24. The firm supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The firm's segments include Life Sciences Services and Life Sciences Products. The firm's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.

功能特性

交易策略

資源

市場

收入

資產負債表

現金流量

年度

每季

CYRX 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
營收	190	228	233	237	222	78
營收年增率 (YoY)	-16%	-2%	-2%	7%	185%	136%
營收成本	101	128	133	133	126	42
毛利	88	99	99	103	96	36
銷售、一般及管理費用	112	148	146	120	97	56
研發	16	17	18	15	16	9
營業費用	129	166	164	135	114	66
其他非營業收入 (費用)	-8	-6	5	-5	-2	0
稅前淨利	-43	-113	-99	-35	-273	-32
所得稅費用	0	1	0	2	1	0
淨利	59	-122	-107	-45	-283	-75
淨利成長	-136%	14%	138%	-84%	277%	317%
稀釋後流通股數	50.12	49.34	48.73	49	45.9	38.6
股數年變動 (YoY)	1%	1%	-1%	7%	19%	16%
每股盈餘 (稀釋)	1.18	-2.48	-2.2	-0.93	-6.18	-1.94
每股盈餘成長率	-135%	13%	137%	-85%	219%	252.99%
自由現金流	-35	-37	-45	-26	-16	-24
每股自由現金流	--	--	--	--	--	--
毛利率	46.31%	43.42%	42.48%	43.45%	43.24%	46.15%
營業利益率	-21.05%	-29.38%	-27.89%	-13.08%	-7.65%	-38.46%
淨利率	31.05%	-53.5%	-45.92%	-18.98%	-127.47%	-96.15%
自由現金流利潤率	-18.42%	-16.22%	-19.31%	-10.97%	-7.2%	-30.76%
EBITDA	-11	-37	-38	-9	3	-21
EBITDA 利潤率	-5.78%	-16.22%	-16.3%	-3.79%	1.35%	-26.92%
EBITDA 中的折舊與攤銷	29	30	27	22	20	9
EBIT	-40	-67	-65	-31	-17	-30
EBIT 利潤率	-21.05%	-29.38%	-27.89%	-13.08%	-7.65%	-38.46%
有效稅率	0%	-0.88%	0%	-5.71%	-0.36%	0%

Follow-Up Questions

Cryoport Inc'in temel mali tabloları nelerdir?



CYRX'ün temel finansal oranları nelerdir?



Cryoport Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?



Cryoport Inc kârlı mı?



Cryoport Inc'in herhangi bir yükümlülüğü var mı?



Cryoport Inc'in tedavüldeki hisse sayısı kaçtır?



Cryoport Inc（CYRX）價格

CYRX 股價走勢圖